Sign In
Buy MRK
$113.87
-1.62 (-1.40%)
At Close: Jun 18, 2026
Merck (MRK) Advances But Underperforms Market: Key Facts
06:47pm, Monday, 08'th Jan 2024
Merck (MRK) reachead $117.38 at the closing of the latest trading day, reflecting a +0.14% change compared to its last close.
How To Build A Dividend Growth Portfolio As A 'Young Investor' With $100,000
03:34pm, Monday, 08'th Jan 2024
How To Build A Dividend Growth Portfolio As A 'Young Investor' With $100,000
Merck Stock's Rally Could Extend to Record Highs
02:55pm, Monday, 08'th Jan 2024
The shares of Merck & Co Inc (NYSE:MRK) are already 7.3% higher since the start of the year, and earlier hit a six-month high of $117.89 before turning lower.
Merck Buys Harpoon Therapeutics To Expand Its Oncology Portfolio
01:55pm, Monday, 08'th Jan 2024
Shares of Harpoon Therapeutics Inc. (HARP) more than doubled Monday after Merck & Co. (MRK) agreed to buy the cancer drug researcher for about $680 million.
Merck to acquire Harpoon Therapeutics in $680M deal
12:56pm, Monday, 08'th Jan 2024
Pharmaceutical company Merck (MRK) will acquire cancer drugmaker Harpoon Therapeutics (HARP) in a deal valued at $680 million. The closing of the acquisition is currently pending, awaiting approval fr
Merck (MRK) Begins Pivotal Studies on Four Cancer Candidates
11:17am, Monday, 08'th Jan 2024
Merck (MRK) begins global pivotal studies on bomedemstat, nemtabrutinib, MK-2870 and MK-5684.
Merck Stock Has Been A Laggard For Seven Months. Is It Staging A Comeback?
09:23am, Monday, 08'th Jan 2024
Merck stock is shrugging off seven months of underperformance, shooting more than 7% higher in the first week of 2024.
J&J, Merck, Boston Scientific Debut Trio Of Splashy Takeovers Topping $3 Billion In Value
09:19am, Monday, 08'th Jan 2024
J&J, Merck and Boston Scientific kicked off the year's biggest medical conference with a trio of takeovers. AMAM stock and HARP stock soared.
Merck's Soaring Stock: Examining The Euphoria Amidst Potential Pitfalls
08:01am, Monday, 08'th Jan 2024
Merck is a pharmaceutical giant whose medications and vaccines play key roles in the fight against viruses, cancer, and cardiovascular diseases. On October 26, 2023, Merck published results for the 3r
Merck to Buy Harpoon Therapeutics for $680 Million
08:00am, Monday, 08'th Jan 2024
Merck has struck a deal to buy clinical-stage immunotherapy company Harpoon Therapeutics for about $680 million.
Merck to buy Harpoon Therapeutics for $680 million
07:36am, Monday, 08'th Jan 2024
Merck & Co said on Monday it would buy cancer drug developer Harpoon Therapeutics for about $680 million, reinforcing its oncology portfolio with immunotherapies.
Merck close to acquiring cancer specialist Harpoon Therapeutics
04:10am, Monday, 08'th Jan 2024
Merck & Co Inc (NYSE:MRK) is close to acquiring Harpoon Therapeutics Inc, a cancer drug developer, for about $700 million to bolster its oncology portfolio. The proposed deal, which could value Harpo
Merck reportedly in talks to buy drugmaker for more than double Friday's price
02:31am, Monday, 08'th Jan 2024
Merck MRK, +0.18% is in talks to buy cancer drugmaker Harpoon Therapeutics HARP, -1.49% for about $700 million, or $23 per share, Bloomberg News reported, citing people familiar with the matter. Merck
Merck in talks to buy Harpoon Therapeutics for around $700 mln - Bloomberg News
12:37am, Monday, 08'th Jan 2024
Merck & Co is in advanced talks to buy cancer drugmaker Harpoon Therapeutics Inc for around $700 million, Bloomberg News reported on Sunday, citing people familiar with the matter.
7 Rock-Solid Healthcare Dividend Stocks to Buy in January
09:10am, Saturday, 06'th Jan 2024
The Pharmaceutical segment offers human health pharmaceutical products in: Oncology, Hospital acute care Immunology Neuroscience Virology Cardiovascular and diabetes Vaccine products, such as preventi
